Inhibition of Cdc37 interaction with heme-regulated [35S]His-tagged eIF2alpha K199R mutant kinase in reticulocyte lysate assessed as coadsorbed Cdc37 at 80 uM after 40 mins by SDS-PAGE and Western blot analysis
Inhibition of Cdc37 interaction with [35S]His-tagged HRI K199R mutant in reticulocyte lysate assessed as coadsorbed Cdc37 at 20 mM after 40 mins by SDS-PAGE and Western blot analysis
Inhibition of Cdc37 interaction with [35S]His-tagged HRI K199R mutant in reticulocyte lysate assessed as coadsorbed Cdc37 at 100 uM after 40 mins by SDS-PAGE and Western blot analysis
Inhibition of Cdc37 interaction with [35S]His-tagged HRI K199R mutant in reticulocyte lysate assessed as coadsorbed Cdc37 at 4 mM after 40 mins by SDS-PAGE and Western blot analysis
Inhibition of Cdc37 interaction with [35S]His-tagged HRI K199R mutant in reticulocyte lysate assessed as coadsorbed Cdc37 at 400 uM after 40 mins by SDS-PAGE and Western blot analysis
Inhibition of Cdc37 interaction with [35S]His-tagged HRI K199R mutant in reticulocyte lysate assessed as coadsorbed Cdc37 at 50 uM after 40 mins by SDS-PAGE and Western blot analysis
Inhibition of Cdc37 in human A549 cells assessed as disruption of HSP90 alpha-Cdc37 interaction by measuring decrease in Cdc37 protein level at 5 uM incubated for 6 hrs by immunoprecipitation based immunoblot analysis
Binding affinity to Cdc37 in human A549 cells assessed as inhibition of HSP90-Cdc37 interaction by measuring decrease in Akt phosphorylation level at 5 uM incubated for 12 hrs by Western blot analysis
Binding affinity to Cdc37 in human A549 cells assessed as inhibition of HSP90-Cdc37 interaction by measuring decrease in CDK4 protein level at 5 uM incubated for 12 hrs by Western blot analysis
Binding affinity to recombinant Cdc37 (unknown origin) assessed as inhibition of biotin labeled 3-[3-cyano-3-(4-fluorophenyl)prop-2-enoyl]oxypropyl(2R,4aS,6aR,6aS,14aS,14bR)-10-hydroxy-2,4a,6a,6a,9,14a-hexamethyl-11-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylate binding to enzyme at 0.25 to 0.5 uM incubated with compound for 2 hrs before or after incubation with biotin labeled 3-[3-cyano-3-(4-fluorophenyl)prop-2-enoyl]oxypropyl(2R,4aS,6aR,6aS,14aS,14bR)-10-hydroxy-2,4a,6a,6a,9,14a-hexamethyl-11-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylate for 2 hrs by pull down assay based immunoblot analysis
Binding affinity to full length CDC37 (unknown origin) assessed as reduction in absorption at 440 nm reaching equilibrium within 15 mins at 100 uM by UV absorption analysis
Binding affinity to Cdc37 in human A549 cells assessed as inhibition of HSP90-Cdc37 interaction by measuring decrease in Akt phosphorylation level incubated for 12 hrs by Western blot analysis
Binding affinity to Cdc37 in human A549 cells assessed as inhibition of HSP90-Cdc37 interaction by measuring decrease in CDK4 protein level incubated for 12 hrs by Western blot analysis
Binding affinity to Cdc37 in human A549 cells assessed as inhibition of HSP90-Cdc37 interaction by measuring increase in BAX protein level at 1.25 to 5 uM incubated for 12 hrs by Western blot analysis
Binding affinity to Cdc37 in human A549 cells assessed as inhibition of HSP90-Cdc37 interaction by measuring increase in cleaved caspase-3 protein level at 1.25 to 5 uM incubated for 12 hrs by Western blot analysis
Binding affinity to Cdc37 in human A549 cells assessed as inhibition of HSP90-Cdc37 interaction by measuring decrease in Bcl2 protein level at 1.25 to 5 uM incubated for 12 hrs by Western blot analysis